BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37677811)

  • 1. Catalytic Tunable Black Phosphorus/Ceria Nanozyme: A Versatile Oxidation Cycle Accelerator for Alleviating Cisplatin-Induced Acute Kidney Injury.
    Gao X; Wang B; Li J; Niu B; Cao L; Liang XJ; Zhang J; Jin Y; Yang X
    Adv Healthc Mater; 2023 Dec; 12(30):e2301691. PubMed ID: 37677811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant nanozymes in kidney injury: mechanism and application.
    Wu J; Shang H; Zhang A; He Y; Tong Y; Huang Q; Liu X; Chen Z; Tang K
    Nanoscale; 2023 Aug; 15(32):13148-13171. PubMed ID: 37547960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-Mediated Artificial Non-Enzymatic Antioxidant MXene Nanoplatforms for Acute Kidney Injury Alleviation.
    Zhao X; Wang LY; Li JM; Peng LM; Tang CY; Zha XJ; Ke K; Yang MB; Su BH; Yang W
    Adv Sci (Weinh); 2021 Sep; 8(18):e2101498. PubMed ID: 34272933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.
    Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y
    Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceria Nanozymes with Preferential Renal Uptake for Acute Kidney Injury Alleviation.
    Zhang DY; Liu H; Li C; Younis MR; Lei S; Yang C; Lin J; Li Z; Huang P
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56830-56838. PubMed ID: 33319561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically translatable gold nanozymes with broad spectrum antioxidant and anti-inflammatory activity for alleviating acute kidney injury.
    Zhang DY; Tu T; Younis MR; Zhu KS; Liu H; Lei S; Qu J; Lin J; Huang P
    Theranostics; 2021; 11(20):9904-9917. PubMed ID: 34815794
    [No Abstract]   [Full Text] [Related]  

  • 7. pH-Activatable Pre-Nanozyme Mediated H
    Jiang W; Hou X; Qi Y; Wang Z; Liu Y; Gao XJ; Wu T; Guo J; Fan K; Shang W
    Adv Sci (Weinh); 2024 May; 11(18):e2303901. PubMed ID: 38445847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect and underlying mechanism of Shenkang injection against cisplatin-induced acute kidney injury in mice.
    Su J; He T; You J; Cao J; Wang Q; Cao S; Mei Q; Zeng J; Liu L
    J Ethnopharmacol; 2023 Jan; 301():115805. PubMed ID: 36216195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of monotropein on alleviating cisplatin-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis.
    Zhang Y; Chen Y; Li B; Ding P; Jin D; Hou S; Cai X; Sheng X
    Biomed Pharmacother; 2020 Sep; 129():110408. PubMed ID: 32574971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS/MAPK signaling pathway.
    Yang F; Jia M; Deng C; Xiao B; Dai R; Xiang Y
    J Mol Histol; 2022 Aug; 53(4):729-740. PubMed ID: 35727472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of Traditional Polyherbs on Cisplatin-Induced Acute Kidney Injury Cell Model by Inhibiting Oxidative Stress and MAPK Signaling Pathway.
    Dachuri V; Song PH; Kim YW; Ku SK; Song CH
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33266089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMF attenuates cisplatin-induced kidney injury via activating Nrf2 signaling pathway and inhibiting NF-kB signaling pathway.
    Zhao K; Wen LB
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8924-8931. PubMed ID: 30575936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water Extract from Brown Strain of
    Chou YN; Lee MM; Deng JS; Jiang WP; Lin JG; Huang GJ
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation.
    Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylenediamine-Based Carbon Nanodots Alleviate Acute Kidney Injury via Preferential Renal Accumulation and Antioxidant Capacity.
    Gao J; Liu Y; Jiang B; Cao W; Kan Y; Chen W; Ding M; Zhang G; Zhang B; Xi K; Jia X; Zhao X; Guo H
    ACS Appl Mater Interfaces; 2020 Jul; 12(28):31745-31756. PubMed ID: 32571010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceria-Zirconia Antioxidant Nanoparticles Attenuate Hypoxia-Induced Acute Kidney Injury by Restoring Autophagy Flux and Alleviating Mitochondrial Damage.
    Hong SE; An JH; Yu SL; Kang J; Park CG; Lee HY; Lee DC; Park HW; Hwang WM; Yun SR; Park MH; Yoon KR; Yoon SH
    J Biomed Nanotechnol; 2020 Jul; 16(7):1144-1159. PubMed ID: 33308381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR2 protects cisplatin-induced acute kidney injury associated with autophagy via PI3K/Akt signaling pathway.
    Shen Q; Zhang X; Li Q; Zhang J; Lai H; Gan H; Du X; Li M
    J Cell Biochem; 2019 Mar; 120(3):4366-4374. PubMed ID: 30387162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-targeted nanoparticles with removing ROS inside and outside mitochondria for acute kidney injury treatment.
    Zhao M; Guo J; Tian C; Yan M; Zhou Y; Liu C; Pang M; Du B; Cheng G
    Nanomedicine; 2024 Jan; 55():102725. PubMed ID: 38007068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effect of 20(R)-Ginsenoside Rg3 Against Cisplatin-Induced Renal Toxicity via PI3K/AKT and NF-[Formula: see text]B Signaling Pathways Based on the Premise of Ensuring Anticancer Effect.
    Zhang JJ; Zhou YD; Liu YB; Wang JQ; Li KK; Gong XJ; Lin XH; Wang YP; Wang Z; Li W
    Am J Chin Med; 2021; 49(7):1739-1756. PubMed ID: 34461812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Acute Kidney Injury with Antioxidative Black Phosphorus Nanosheets.
    Hou J; Wang H; Ge Z; Zuo T; Chen Q; Liu X; Mou S; Fan C; Xie Y; Wang L
    Nano Lett; 2020 Feb; 20(2):1447-1454. PubMed ID: 31975594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.